San Diego, CA -- (SBWIRE) -- 10/19/2015 -- A shareholder in shares of Globus Medical Inc (NYSE:GMED) filed a lawsuit against Globus Medical Inc over alleged securities laws violations in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Globus Medical Inc (NYSE:GMED) have certain options and for certain investors are short and strict deadlines running. Deadline: November 30, 2015. NYSE:GMED investors should contact the Shareholders Foundation at mail@shareholdersfoundation or call 858-779-1554.

The plaintiff alleges on behalf of purchasers of Globus Medical Inc (NYSE:GMED) common shares between February 26, 2014 through August 5, 2014, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 26, 2014 through August 5, 2014 issued materially false and misleading statements to investors and/or failed to disclose that Globus Medical's relationship with a significant distributor was deteriorating, that such deterioration was negatively impacting Globus Medical's financial performance, and that as a result of the foregoing, defendants' statements about Globus Medical's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

On August 5, 2014, Globus Medical Inc announced its financial results for the 2014 second quarter and lowered its revenue guidance for the 2014 year. Shares of Globus Medical Inc (NYSE:GMED) declined to as low as $18.14 per share in late August 2014.

Those who purchased shares of Globus Medical Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com